Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR

Auton Autacoid Pharmacol. 2012 Oct;32(3 Pt 4):61-9. doi: 10.1111/aap.12001.

Abstract

We investigated captopril effects, an ACE inhibitor, on hypertension development, on Ang II and Ang-(1-7) plasma concentrations, on Ang II-induced contraction in isolated kidneys, and on kidney AT1R from spontaneously hypertensive (SHR) rats. Five weeks-old SHR and Wistar Kyoto (WKY) rats were treated with captopril at 30 mg/kg/day, in drinking water for 2 or 14 weeks. Systolic blood pressure (SBP) was measured, and isolated kidneys were tested for perfusion pressure and AT1R expression; while Ang II and Ang-(1-7) concentrations were determined in plasma. Captopril did not modify SBP in WKY rats and avoided its increase as SHR aged. Plasma Ang-II concentration was ∼4-5 folds higher in SHR rats, and captopril reduced it (P<0.05); while captopril increased Ang-(1-7) by ∼2 fold in all rat groups. Captopril increased Ang II-induced pressor response in kidneys of WKY and SHR rats, phenomenon not observed in kidneys stimulated with phenylephrine, a α₁-adrenoceptor agonist. Captopril did not modify AT1R in kidney cortex and medulla among rat strains and ages. Data indicate that captopril increased Ang II-induced kidney perfusion pressure but not AT₁R density in kidney of WKY and SHR rats, due to blockade of angiotensin II synthesis; however, ACE inhibitors may have other actions like activating signaling processes that could contribute to their diverse effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Angiotensin I / blood
  • Angiotensin II / blood*
  • Angiotensin II / metabolism
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Animals
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects
  • Captopril / adverse effects
  • Captopril / therapeutic use*
  • Hypertension / etiology
  • Hypertension / prevention & control*
  • Kidney / blood supply
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / physiopathology
  • Kidney Cortex / drug effects
  • Kidney Cortex / metabolism
  • Kidney Medulla / drug effects
  • Kidney Medulla / metabolism
  • Male
  • Peptide Fragments / blood
  • Prehypertension / blood
  • Prehypertension / drug therapy*
  • Prehypertension / metabolism
  • Prehypertension / physiopathology
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Receptor, Angiotensin, Type 1 / metabolism
  • Specific Pathogen-Free Organisms
  • Vascular Resistance / drug effects*

Substances

  • Agtr1a protein, rat
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Peptide Fragments
  • Receptor, Angiotensin, Type 1
  • Angiotensin II
  • Angiotensin I
  • Captopril
  • angiotensin I (1-7)